Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib plus paracetamol to reduce opioid consumption after breast cancer surgery
TCTR20230301004Phase 2Completed
- Sponsor
- Faculty of Medicine, Khon Kaen University
- Start
- Aug 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of parecoxib and acetaminophen in breast cancer (2 arms), sponsored by Faculty of Medicine, Khon Kaen University. Primary endpoint: Postoperative opioid consumption. Started Aug 2021; status: completed.
02
Drugs
parecoxibacetaminophen
03
Conditions
breast cancer
Beyond the preview
Go deeper on TCTR20230301004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230301004.